data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Contribute
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZEQTQ0IiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBkPSJNMCA4NS4zMzFoNTEydjExMy43NzVIMHptMCAyMjcuNTUxaDUxMnYxMTMuNzc1SDB6IiBmaWxsPSIjRDgwMDI3Ii8+PC9zdmc+Español
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMzQxLjMzNCA4NS4zM0gwdjM0MS4zMzJoNTEyVjg1LjMzeiIvPjxwYXRoIGZpbGw9IiM2REE1NDQiIGQ9Ik0wIDg1LjMzM2gxNzAuNjYzVjQyNi42N0gweiIvPjxwYXRoIGZpbGw9IiNEODAwMjciIGQ9Ik0zNDEuMzM3IDg1LjMzM0g1MTJWNDI2LjY3SDM0MS4zMzd6Ii8+PC9zdmc+Italiano
data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIHZpZXdCb3g9IjAgODUuMzMzIDUxMiAzNDEuMzMzIj48cGF0aCBmaWxsPSIjRkZGIiBkPSJNMCA4NS4zMzFoNTEydjM0MS4zMzdIMHoiLz48cGF0aCBmaWxsPSIjMDA1MkI0IiBkPSJNMCA4NS4zMzFoMTcwLjY2M3YzNDEuMzM3SDB6Ii8+PHBhdGggZmlsbD0iI0Q4MDAyNyIgZD0iTTM0MS4zMzcgODUuMzMxSDUxMnYzNDEuMzM3SDM0MS4zMzd6Ii8+PC9zdmc+Français
Personal Finance
Alts
Best Real Estate Crowdfunding Platforms
REITs Versus Crowdfunding
How to Invest in Artwork
Best Alternative Investments
Best Alternative Investment Platforms
Crypto
Cannabis
News
Earnings
Interviews
Deals
Regulations
Psychedelics
TV
YouTube
Video
Podcasts
Trading School
My Stocks
Tools
Premium
QQQ
––%
DIA
––%
SPY
––%
TLT
––%
GLD
––%
BTC/USD
––%
Imago BioSciences
(NASDAQ:IMGO)
$14.15
0.76[5.68%]
At close: Jul 1
$14.15
00
After Hours: 4:01PM EDT
Day High/Low12.91 - 14.41
52 Week High/Low11.56 - 35.68
Open / Close13.38 / 14.15
Float / Outstanding25.1M / 33.7M
Vol / Avg.73.8K / 188.8K
Mkt Cap477.4M
P/E-
50d Avg. Price14.98
Div / Yield-
Payout Ratio-
EPS-0.49
Total Float25.1M

Imago BioSciences (NASDAQ:IMGO), Quotes and News Summary

Imago BioSciences (NASDAQ: IMGO)

Day High/Low12.91 - 14.41
52 Week High/Low11.56 - 35.68
Open / Close13.38 / 14.15
Float / Outstanding25.1M / 33.7M
Vol / Avg.73.8K / 188.8K
Mkt Cap477.4M
P/E-
50d Avg. Price14.98
Div / Yield-
Payout Ratio-
EPS-0.49
Total Float25.1M
Benzinga - May 12, 2022, 5:29PM
Benzinga - May 9, 2022, 8:09AM
Benzinga - May 3, 2022, 8:10AM
Benzinga - Mar 25, 2022, 6:23AM
Benzinga - Mar 24, 2022, 4:18PM
Benzinga - Mar 23, 2022, 4:47PM
Benzinga - Mar 23, 2022, 4:07PM
Benzinga - Feb 14, 2022, 6:08AM
Benzinga - Dec 13, 2021, 11:47AM
Benzinga - Dec 12, 2021, 11:00AM
Benzinga - Dec 11, 2021, 12:23PM
Benzinga - Nov 10, 2021, 5:09PM
Benzinga - Sep 30, 2021, 4:59PM
Benzinga - Sep 20, 2021, 8:14AM
Benzinga - Sep 9, 2021, 9:37AM
load more
Sector: Health Care.Industry: Biotechnology
Imago BioSciences Inc is a clinical-stage biopharmaceutical company discovering and developing novel small molecule product candidates that target lysine-specific demethylase 1 (LSD1), an enzyme that plays a central role in the production of blood cells in the bone marrow. It is focused on improving the quality and length of life for patients with cancer and bone marrow diseases. Bomedemstat, an orally available, small molecule inhibitor of LSD1, is the product candidate discovered by Imago for the treatment of certain myeloproliferative neoplasms (MPNs), a family of related, chronic cancers of the bone marrow. Imago is evaluating Bomedemstat as a potentially disease-modifying therapy in two Phase 2 clinical trials for the treatment of essential thrombocythemia (ET) and myelofibrosis (MF).
Read More

Earnings

see more
Q2 2022Est.ActualSurprise
EPS
(EXPECTED)2022-08-18
REV
Q1 2022Est.ActualSurprise
EPS-0.490
REV0

Analyst Ratings

see more
DateAnalyst FirmAnalyst NameActionRatingAction Price Prior Price Target

Imago BioSciences Questions & Answers

Q
How do I buy Imago BioSciences (IMGO) stock?
A

You can purchase shares of Imago BioSciences (NASDAQ: IMGO) through any online brokerage.

View our list of the best stock brokerages.

Q
Who are Imago BioSciences's (IMGO) competitors?
Q
What is the target price for Imago BioSciences (IMGO) stock?
A

The latest price target for Imago BioSciences (NASDAQ: IMGO) was reported by HC Wainwright & Co. on Friday, March 25, 2022. The analyst firm set a price target for 36.00 expecting IMGO to rise to within 12 months (a possible 154.42% upside). 6 analyst firms have reported ratings in the last year.

Q
Current Stock Price for Imago BioSciences (IMGO)?
A

The stock price for Imago BioSciences (NASDAQ: IMGO) is $14.15 last updated July 1, 2022, 8:00 PM UTC.

Q
Does Imago BioSciences (IMGO) pay a dividend?
A

There are no upcoming dividends for Imago BioSciences.

Q
When is Imago BioSciences (NASDAQ:IMGO) reporting earnings?
A

Imago BioSciences’s Q2 earnings are confirmed for Thursday, August 18, 2022.

Q
Is Imago BioSciences (IMGO) going to split?
A

There is no upcoming split for Imago BioSciences.

Q
What sector and industry does Imago BioSciences (IMGO) operate in?
A

Imago BioSciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.